Case Report
BibTex RIS Cite

Ramadan fasting and diabetes: view with case reports

Year 2019, , 102 - 106, 01.07.2019
https://doi.org/10.32322/jhsm.439193

Abstract

Apart from Islam, Christianity, Judaism, and many other religions such as Hinduism, Buddhism have fast worship, and Christians also have worship in certain periods of the year as in Islam. It is estimated that 1.5 billion people fasted all over the world during Ramadan. According to the countries and the fasting season, the period of fasting can vary between 9-21 hours. Some patients are told that they should not consult fasting physicians and fasting under physician control, or that some patients should not fast by the physician. But most importantly, some patients are fasting without medication consultation and face serious health problems. As the studies about fasting increase, many studies have shown that many patients can safely fast by physician control and regular follow-ups. We also wanted to share the follow-up results of three types of diabetic patients reporting fasting and fasting in this article at their own discretion.


References

  • 1. https://www.sabah.com.tr/fotohaber/yasam/hangi-ulkede-kac-saat-oruc-tutuluyor-en-uzun-sure-oruc-tutulan-ulke-hangisi/2.
  • 2. Bravis V, Hui E, Salih S, et al. Ramadan education and awareness in diabetes (READ) programme for muslims with Type 2 diabetes who fast during Ramadan. Diabet Med 2010; 27: 327-31.
  • 3. Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010; 33: 1895-902.
  • 4. Hassanein M, Al-Arouj M, Ben-Nakhi A, et al. Diabetes and Ramadan: Practical Guidelines. IDF, in collaboration with the Diabetes and Ramadan (DAR) International Alliance, April 2016.
  • 5. El Toony LF, Hamad DA, Omar OM.. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2018 Apr 25. pii: S1871-4021(18)30141-3. doi: 10.1016/j.dsx.2018.04.036 [Epub ahead of print].
  • 6. Bashir M, Elhadd T, Ali H, et al. A pilot study using flash continuous glucose monitoring in patients with type 2 diabetes on multiple antidiabetic agents during Ramadan. Diabetes Metab Syndr 2018 Jun 7. pii: S1871-4021(18)30210-8. doi: 10.1016/j.dsx.2018.06.005 [Epub ahead of print].
  • 7. Özkara A, Ateş İ, Altay M. https://www.medimagazin.com.tr/guncel/genel/tr-hekimler-icin-oruc-tutmak-isteyen-diabet-hastalarina-yonelik-bilimsel-degerlendirme-ve-takip-kilavuzu-11-681-77088.html.
  • 8. Demir ME. Böbrek hastaları ve oruç ibadeti. J Health Sci Med 2018; 1: 21-22.
  • 9. Hejaili F, Qurashi S, Binsalih S, Jaradt M, Al Sayyari A. Effect of repeated ramadan fasting in the hottest months of the year on renal graft function. Nephrourol Mon 2014 Mar 1; 6:e14362. doi: 10. 5812/numonthly.14362. eCollection 2014 Mar.
  • 10. Boobes Y, Bernieh B, Al Hakim MR. Fasting Ramadan in kidney transplant patients is safe. Saudi J Kidney Dis Transpl 2009 Mar; 20: 198-200.
  • 11. Shao Y, Lim GJ, Chua CL .. The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes. Diabetes Res Clin Pract 2018 May 24; 142: 85-91. doi: 10.1016/j.diabres.2018.05.022 [Epub ahead of print].
  • 12. Bashier A, Khalifa AA, Abdelgadir EI, et al. Safety of sodium-glucose cotransporter inhibitors (SGLT2-I) during the month of Ramadan in Muslim patients with type 2 diabetes. Oman Med J 2018; 33: 104-10.
  • 13. Nematy M, Alinezhad-Namaghi M, Rashed MM, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutrition J 2012; 11: 69.
  • 14. Altunkeser A. The effect of Ramaddan fasting on fetal/obstetric B-mode and doppler ultrasound findings. Ortadogu Med J 2018; 10: 1-17.

Oruç ibadeti ve diyabet: olgu örnekleriyle bakış

Year 2019, , 102 - 106, 01.07.2019
https://doi.org/10.32322/jhsm.439193

Abstract

İslamiyet dışında Hıristiyanlık,
Yahudilik gibi semavi dinlerde ve Hinduizm, Budizm gibi daha pek dinde oruç
ibadeti vardır ve Hıristiyanlarda da İslamiyet’te olduğu gibi yılın belli
dönemlerinde farz ibadet olarak geçmektedir. Tüm dünyada Ramazan ayında 1,5
milyar kişinin oruç tuttuğu tahmin edilmektedir. Ülkelere ve oruç tutulan
mevsimlere göre oruçlu olunan 9-21 saat arasında değişebilmektedir. Bazı
hastalar hekime danışıp hekim kontrolünde oruç tutmakta veya bazı hastalara da
hekim tarafından oruç tutmaması gerektiği söylenmektedir. Ama en önemlisi bazı
hastalar hiç hekime danışmadan oruç tutmakta ve ciddi sağlık problemleriyle
karşılaşmakta hatta hayattalarını kaybedebilmektedir. Oruçla ilgili yapılan
çalışmalar arttıkça pek çok hasta grubunun hekim kontrolünde ve düzenli
takiplerine gelerek güvenle oruç tutabildiği pek çok çalışmada gösterilmiştir.
Biz de kendi isteği ile her halükarda ben oruç tutacağını beyan eden ve bu
taleple polikliniğe başvuran pek çok hastamızdan üçünün takip sonuçlarını paylaşmak
istedik.

References

  • 1. https://www.sabah.com.tr/fotohaber/yasam/hangi-ulkede-kac-saat-oruc-tutuluyor-en-uzun-sure-oruc-tutulan-ulke-hangisi/2.
  • 2. Bravis V, Hui E, Salih S, et al. Ramadan education and awareness in diabetes (READ) programme for muslims with Type 2 diabetes who fast during Ramadan. Diabet Med 2010; 27: 327-31.
  • 3. Al-Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010; 33: 1895-902.
  • 4. Hassanein M, Al-Arouj M, Ben-Nakhi A, et al. Diabetes and Ramadan: Practical Guidelines. IDF, in collaboration with the Diabetes and Ramadan (DAR) International Alliance, April 2016.
  • 5. El Toony LF, Hamad DA, Omar OM.. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2018 Apr 25. pii: S1871-4021(18)30141-3. doi: 10.1016/j.dsx.2018.04.036 [Epub ahead of print].
  • 6. Bashir M, Elhadd T, Ali H, et al. A pilot study using flash continuous glucose monitoring in patients with type 2 diabetes on multiple antidiabetic agents during Ramadan. Diabetes Metab Syndr 2018 Jun 7. pii: S1871-4021(18)30210-8. doi: 10.1016/j.dsx.2018.06.005 [Epub ahead of print].
  • 7. Özkara A, Ateş İ, Altay M. https://www.medimagazin.com.tr/guncel/genel/tr-hekimler-icin-oruc-tutmak-isteyen-diabet-hastalarina-yonelik-bilimsel-degerlendirme-ve-takip-kilavuzu-11-681-77088.html.
  • 8. Demir ME. Böbrek hastaları ve oruç ibadeti. J Health Sci Med 2018; 1: 21-22.
  • 9. Hejaili F, Qurashi S, Binsalih S, Jaradt M, Al Sayyari A. Effect of repeated ramadan fasting in the hottest months of the year on renal graft function. Nephrourol Mon 2014 Mar 1; 6:e14362. doi: 10. 5812/numonthly.14362. eCollection 2014 Mar.
  • 10. Boobes Y, Bernieh B, Al Hakim MR. Fasting Ramadan in kidney transplant patients is safe. Saudi J Kidney Dis Transpl 2009 Mar; 20: 198-200.
  • 11. Shao Y, Lim GJ, Chua CL .. The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes. Diabetes Res Clin Pract 2018 May 24; 142: 85-91. doi: 10.1016/j.diabres.2018.05.022 [Epub ahead of print].
  • 12. Bashier A, Khalifa AA, Abdelgadir EI, et al. Safety of sodium-glucose cotransporter inhibitors (SGLT2-I) during the month of Ramadan in Muslim patients with type 2 diabetes. Oman Med J 2018; 33: 104-10.
  • 13. Nematy M, Alinezhad-Namaghi M, Rashed MM, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutrition J 2012; 11: 69.
  • 14. Altunkeser A. The effect of Ramaddan fasting on fetal/obstetric B-mode and doppler ultrasound findings. Ortadogu Med J 2018; 10: 1-17.
There are 14 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Report
Authors

Merve Lehimcioğlu This is me

İrfan Karahan

Aşkın Güngüneş

Aydın Çifci

Publication Date July 1, 2019
Published in Issue Year 2019

Cite

AMA Lehimcioğlu M, Karahan İ, Güngüneş A, Çifci A. Oruç ibadeti ve diyabet: olgu örnekleriyle bakış. J Health Sci Med / JHSM. July 2019;2(3):102-106. doi:10.32322/jhsm.439193

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.